NasdaqGM - Nasdaq Real Time Price USD
Trevi Therapeutics, Inc. (TRVI)
6.60
0.00
(0.00%)
At close: May 9 at 4:00:00 PM EDT
6.44
-0.16
(-2.42%)
After hours: May 9 at 7:59:14 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-38,256
-38,256
-31,710
-28,175
-28,946
Investing Cash Flow
-21,528
-21,528
59,428
-107,373
0
Financing Cash Flow
61,484
61,484
-7,910
111,307
20,775
End Cash Position
34,097
34,097
32,397
12,589
36,830
Interest Paid Supplemental Data
4
4
331
594
603
Capital Expenditure
-35
-35
-137
-159
--
Issuance of Capital Stock
61,146
61,146
1,710
105,410
21,183
Issuance of Debt
--
--
--
--
0
Repayment of Debt
-126
-126
-9,504
-5,833
0
Repurchase of Capital Stock
-1,213
--
--
--
--
Free Cash Flow
-38,291
-38,291
-31,847
-28,334
-28,946
12/31/2021 - 5/7/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CGEM Cullinan Therapeutics, Inc.
7.54
-2.96%
LXEO Lexeo Therapeutics, Inc.
2.6900
-10.33%
RZLT Rezolute, Inc.
3.7000
-0.54%
BCAX Bicara Therapeutics Inc.
12.97
-1.22%
ORIC ORIC Pharmaceuticals, Inc.
5.08
-4.51%
EWTX Edgewise Therapeutics, Inc.
14.58
-0.82%
MLYS Mineralys Therapeutics, Inc.
14.65
-6.15%
PTGX Protagonist Therapeutics, Inc.
42.97
-2.16%
JANX Janux Therapeutics, Inc.
25.56
-3.07%
XENE Xenon Pharmaceuticals Inc.
35.02
-1.46%